Synthetic routes to [glucose-U-C-14]-1-O-(beta-D-glucopyranosyl)-N-stearoyl
-D-erythro-sphingosine 1b and to [glucose-C-13(6)]-1-O-(beta-D-glucopyranos
yl)sphingosine ([glucose-C-13(6)]glucopsychosine, 2b) are described. Wherea
s the protected ceramide precursor for 1b was prepared using conventional m
ethodology, two new strategies were developed in the course of the synthesi
s of 2b. Of these, one relies on keeping a protecting group in place at all
times to avoid the handling difficulties associated with sphingosine 4, wh
ile the other generates a protected derivative (24) of sphingosine indirect
ly by means of a Mitsunobu inversion.